Blake Zobell, DPM
Podiatrist · Richfield, UTNPI 1720026560
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Stryker at 54.0% of the total. That places this record below the midpoint for podiatrist clinicians in UT, where the typical reported total is $963.
Across 53 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$591
- Axogen$106
- Lilly USA, LLC$82
- Treace Medical Concepts, Inc.$64
- Amgen$46
- Organogenesis Inc.$40
- plus $165 from 8 others
What the payments were for
- Food & beverage$1,094100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 31 | $591 |
| Axogen | 1 | $106 |
| Lilly USA, LLC | 5 | $82 |
| Treace Medical Concepts, Inc. | 1 | $64 |
| Amgen | 3 | $46 |
| Organogenesis Inc. | 2 | $40 |
| Paragon 28, Inc. | 2 | $33 |
| Novo Nordisk | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Medtronic | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| AstraZeneca | 1 | $13 |
How this compares
$1,094 in reported general payments places this provider in the 50th percentile of 59 podiatrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 62 | $844 |
| Gabapentin | 43 | $785 |
| Terbinafine Hcl | 19 | $442 |
| Cephalexin | 33 | $228 |
| Naproxen | 15 | $152 |
| Meloxicam | 15 | $121 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Richfield
- Jason BruseLayton$203K
- Anna HronekSalt Lake City$82K
- Michele CarrDraper$56K
- David GraffOgden$39K
- Clark LarsenMurray$16K
- Kelly HamblinWest Jordan$13K
- Mikol AndersonSalt Lake City$9K
- Thomas EddyMurray$7K
- Andrew EvansSt George$6K
- Jason LucasOgden$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.